Over-expression of Long Non-coding RNA Urothelial Cancer-associated 1 as a Predictive Marker for Prostate Cancer
In Vivo · 2023
DOI: 10.21873/invivo.13236 ↗Kurz gefasst
Fachartikel in der Zeitschrift In Vivo, 2023. Verfasst von Yoo Jin Lee und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Korea University Anam Hospital, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Carcinoma, Transitional Cell, Prostatic Neoplasms, RNA, Long Noncoding, Urinary Bladder Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Korea University Anam Hospital, Seoul, Republic of Korea.
- Department of Urology, Korea University Anam Hospital, Seoul, Republic of Korea.
- Department of Pathology, Korea University Anam Hospital, Seoul, Republic of Korea; chkap@korea.ac.kr.
Zitieren
APA
Lee, Y. J., Kang, S. G., & Kim, C. H. (2023). Over-expression of Long Non-coding RNA Urothelial Cancer-associated 1 as a Predictive Marker for Prostate Cancer. In Vivo. https://doi.org/10.21873/invivo.13236
Vancouver
Lee YJ, Kang SG, Kim CH. Over-expression of Long Non-coding RNA Urothelial Cancer-associated 1 as a Predictive Marker for Prostate Cancer. In Vivo. 2023. doi:10.21873/invivo.13236
BibTeX
@article{Lee2023,
author = {Lee, Yoo Jin and Kang, Sung Gu and Kim, Chul Hwan},
title = {Over-expression of Long Non-coding RNA Urothelial Cancer-associated 1 as a Predictive Marker for Prostate Cancer},
journal = {In Vivo},
year = {2023},
doi = {10.21873/invivo.13236}
}
EUVIMED